TAK-994
TAK-994-1501
Phase 2 small_molecule terminated
Quick answer
TAK-994 for Narcolepsy Type 1 (NT1) is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Narcolepsy Type 1 (NT1)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated